For contacts, reduces your risk of developing disease, so that's how we're focusing our vaccination efforts at this point, she said. 'We're using it in individuals who we believe are at high risk of developing symptoms, and using it early, particularly within four or five days of the case developing symptoms.
'We're not using (the vaccine) in the general population,' Dr Susan Hopkins, UKHSA Chief Medical Adviser, told the BBC. The agency is also providing close contacts of such cases with an established smallpox vaccine that can help protect against monkeypox.
